Next Article in Journal
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
Next Article in Special Issue
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
Previous Article in Journal
Sirtuins and Hypoxia in EMT Control
Previous Article in Special Issue
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(6), 738; https://doi.org/10.3390/ph15060738
Action Date Notes Link
article pdf uploaded. 11 June 2022 11:37 CEST Version of Record https://www.mdpi.com/1424-8247/15/6/738/pdf-vor
article pdf uploaded. 13 June 2022 03:10 CEST Updated version of record https://www.mdpi.com/1424-8247/15/6/738/pdf-vor
article xml file uploaded 15 June 2022 09:42 CEST Original file -
article xml uploaded. 15 June 2022 09:42 CEST Update -
article pdf uploaded. 15 June 2022 09:42 CEST Updated version of record https://www.mdpi.com/1424-8247/15/6/738/pdf-vor
article html file updated 15 June 2022 09:44 CEST Original file -
article xml file uploaded 22 June 2022 02:37 CEST Update -
article xml uploaded. 22 June 2022 02:37 CEST Update https://www.mdpi.com/1424-8247/15/6/738/xml
article pdf uploaded. 22 June 2022 02:37 CEST Updated version of record https://www.mdpi.com/1424-8247/15/6/738/pdf
article html file updated 22 June 2022 02:39 CEST Update https://www.mdpi.com/1424-8247/15/6/738/html
Back to TopTop